-
Founded in:
1994-12-24 -
Country:
China -
Address:
4th Floor, Building 1, Bitongyuan, No. 69, Fushi Road, Haidian District, Beijing -
Tax NO.:
91110000102299779W -
Registered Funds:
1,027.35 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytidine 5'-triphosphate disodium salt |
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.
More
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism. |
36051-68-0 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytidine 5'-triphosphate disodium salt |
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.
More
Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism. |
36051-68-0 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| HumanGranulocyteColonyStimulatingFactor |
This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminal undifferentiated cells.
More
This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of granulocyte terminal undifferentiated cells. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| HumanGranulocyteColonyStimulatingFactor |
This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.
More
This product is human granulocyte colony stimulating factor (rhG-CSF) produced by gene recombination technology. Compared with natural products, its biological activity is basically the same in vivo and in vitro. rhG-CSF is one of the main cytokines that regulate granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naftopidil dihydrochloride |
Naftopidil is a selective alpha 1 receptor antagonist that can inhibit the increase in blood pressure caused by alpha 1 receptors. It has a hypotensive effect on a variety of hypertensive animal models, with a long duration of hypotensive effect, and does not cause reflex tachycardia during hypotensive treatment. No obvious first-dose effect or drug resistance was observed after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the alpha 1 receptor blocking effect, reduce the intraurethral pressure, and improve the symptoms of urination disorders caused by benign prostatic hyperplasia.
More
Naftopidil is a selective alpha 1 receptor antagonist that can inhibit the increase in blood pressure caused by alpha 1 receptors. It has a hypotensive effect on a variety of hypertensive animal models, with a long duration of hypotensive effect, and does not cause reflex tachycardia during hypotensive treatment. No obvious first-dose effect or drug resistance was observed after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the alpha 1 receptor blocking effect, reduce the intraurethral pressure, and improve the symptoms of urination disorders caused by benign prostatic hyperplasia. |
57149-07-2 | 13 |